Isolated intestinal versus composite visceral allografts: causes of graft failure

Although tacrolimus-based immunosuppression has made clinical intestinal transplantation feasible, the risk of the requisite long-term high-dose treatment has inhibited the widespread use of these procedures. 1 Such a risk could be partially eliminated with safe adjustment of the current immunosuppressive management protocol according to the type of intestinal allograft.